Organigram Holdings Stock News

OrganiGram (OGI) delivered earnings and revenue surprises of 0% and 3.44%, respectively, for the quarter ended November 2021. Do the numbers hold clues to what lies ahead for the stock?

Top Canadian Marijuana Stocks To Buy In 2022? These Could Be The Ones To Watch The post Are These The Best Canadian Marijuana Stocks To Buy In 2022? appeared first on Marijuana Stocks | Cannabis Inves

Canadian cannabis company Organigram Holdings Inc. OGI, +6.79% said Tuesday it had a net loss of C$1.305 million ($1.0 million) in its fiscal first quarter to Nov. 30, narrower than the loss of C$34.3

On January 11, OrganiGram will report earnings from Q1. Wall Street predict expect OrganiGram will report losses per share of CAD 0.034 Go here to watch OrganiGram stock price in real-time on Markets Insider. On January…

Top Penny Stocks To Watch In The Cannabis Sector The post Canadian Marijuana Stocks To Watch Right Now? 2 Penny Stocks For Active Traders In 2022 appeared first on Marijuana Stocks | Cannabis Investme

MONCTON, New Brunswick--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed

OrganiGram (OGI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OrganiGram (OGI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Canadian Pot Stocks For Your 2022 Watchlist The post Canadian Marijuana Stocks To Watch Before January 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Indus

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to sha

3 Canadian Marijuana Stocks To Watch In 2022 The post 3 Canadian Marijuana Stocks To Watch Before The Start Of 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Buddi

Raymond James reissued their outperform rating on shares of OrganiGram (TSE:OGI) in a report released on Wednesday morning, Analyst Price Targets reports. Raymond James currently has a C$5.00 price objective on the stock. Other equities analysts also recently issued reports about the company. CIBC reiterated a neutral rating on shares of OrganiGram in a research [] The post OrganiGrams (OGI) Outperform Rating Reaffirmed at Raymond James appeared first on ETF Daily News .

Organigram Makes Additional $2.5 Million Investment in Hyasynth Biologicals, a Leading Cannabinoid